Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (231-240 of 536) with videos related to

Pageof 54
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2011
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncologyPhillip G Febbo, Marc Ladanyi, Kenneth D Aldape, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformationAnn-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Leukemia Research|September 15, 2022
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclaxJan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
Haematologica|May 13, 2021
Targeting BRD4 in acute myeloid leukemia with partial tandem duplication of the <i>MLL</i> geneMarius Bill, Chinmayee Goda, Felice Pepe, et al.
Blood|June 21, 2008
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplicationSusan P Whitman, Björn Hackanson, Sandya Liyanarachchi, et al.
Molecular Pharmaceutics|April 15, 2015
CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous LeukemiaHong Li, Songlin Xu, Jishan Quan, et al.
Blood|March 22, 2003
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP proteinJennifer L Aron, Mark R Parthun, Guido Marcucci, et al.
Blood|May 31, 2012
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instabilityLiran I Shlush, Noa Chapal-Ilani, Rivka Adar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemiaRebecca B Klisovic, William Blum, Xiaohui Wei, et al.
Journal of Hematology & Oncology|March 19, 2013
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemiaHouda Alachkar, Ramasamy Santhanam, Jason G Harb, et al.
Pageof 54

Showing results (231-240 of 536) with videos related to

Sort By:
Pageof 54
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2011
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncologyPhillip G Febbo, Marc Ladanyi, Kenneth D Aldape, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2014
NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformationAnn-Kathrin Eisfeld, Sebastian Schwind, Kevin W Hoag, et al.
Leukemia Research|September 15, 2022
Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclaxJan Philipp Bewersdorf, Rory M Shallis, Andriy Derkach, et al.
Haematologica|May 13, 2021
Targeting BRD4 in acute myeloid leukemia with partial tandem duplication of the <i>MLL</i> geneMarius Bill, Chinmayee Goda, Felice Pepe, et al.
Blood|June 21, 2008
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplicationSusan P Whitman, Björn Hackanson, Sandya Liyanarachchi, et al.
Molecular Pharmaceutics|April 15, 2015
CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous LeukemiaHong Li, Songlin Xu, Jishan Quan, et al.
Blood|March 22, 2003
Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP proteinJennifer L Aron, Mark R Parthun, Guido Marcucci, et al.
Blood|May 31, 2012
Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instabilityLiran I Shlush, Noa Chapal-Ilani, Rivka Adar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemiaRebecca B Klisovic, William Blum, Xiaohui Wei, et al.
Journal of Hematology & Oncology|March 19, 2013
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemiaHouda Alachkar, Ramasamy Santhanam, Jason G Harb, et al.
Pageof 54